Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 1997

Deterministic assessment of the risk of sudden death in hypertrophic cardiomyopathy

Piotr Walichiewicz, Michał Tendera

Med Sci Monit 1997; 3(5): CR692-699 :: ID: 501614

Abstract

Over the course of a long-term follow-up, ranging from 1 to 24 years, data regarding syncope, chest pain, palpitations, dyspnea on exertion, the presence of the disease in other family members, electrocardiographic and echocardiographic changes and the risk of sudden death among patients with hypertrophic cardiomyopathy were prospectively collected. one hundred and twenty-five patients were included in the study (78 men and 47 women). Their mean age was 41 years (±12). Twenty patients (16%) died suddenly during the study. Deterministic analysis, using the method of rough-sets theory, showed common electrocardiographic and echocardiographic features for all the patients who died suddenly. Electrocardiographic features indicative of the risk of sudden death are different for different types of hypertrophy. type II hypertrophy, the risk of sudden death exists when the ECG demonstrates either right ventricular hypertrophy or P mitrale in the absence of pathological anterior Q waves and bundle branch block, or when anterior Q waves, RVH, and P mitrale occur simultaneously in the absence of bundle branch block. For type III hypertrophy, the risk of sudden death exists when the ECG presents no more than one of the three following features: anterior Q waves, right ventricular hypertrophy or P mitrale, in the absence of bundle branch block or when anterior Q waves, RVH and P mitrale (all three features) occur simultaneously in the absence of bundle branch block.In both types (II and III) of hypertrophy, however the risk of sudden death can also exist when none of the above mentioned changes (pathological anterior Q waves, right ventricular hypertrophy, P mitrale and bundle branch block) occurs. In patients with type IV hypertrophy we found the risk of sudden death to be low. There are common electrocardiographic and echocardiographic features characteristic for all the patients with hypertrophic cardiomyopathy who die suddenly. These risk factors of sudden death exist innearly 60% patients with hypertrophic cardiomyopathy.

Keywords: hypertrophic cardiomyopathy, sudden death, deterministic assessment

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750